Core Viewpoint - The company has decided to terminate part of its fundraising projects and delay others, based on a careful assessment of the current market conditions and project progress, ensuring that these decisions align with the long-term interests of the company and its shareholders [1][10]. Fundraising Overview - The company raised a net amount of RMB 1,002,572,682.71 through its initial public offering, verified by an accounting firm [1]. - The company has established a management system for the use of raised funds, ensuring that funds are stored in dedicated accounts and used strictly for their intended purposes [2]. Termination of Fundraising Projects - The project "Zihang Medical Device Component Intelligent Manufacturing and Expansion Project" will be terminated, with the total investment amount reduced from RMB 282.84 million to RMB 143.47 million, and the fundraising investment amount decreased from RMB 282.84 million to RMB 135.77 million [3]. - The termination is influenced by changes in market demand and increased competition, leading to a reassessment of the project's viability [6][7]. Reasons for Project Termination - The implementation of centralized procurement policies has created volatility in market demand, affecting the sales cycle and capacity planning for the project [6]. - The existing production capacity is deemed sufficient to meet current demand, and further investment could lead to idle capacity risks [7]. Impact of Project Termination - The termination is expected to enhance the efficiency of fundraising usage and will not adversely affect the company's normal operations or shareholder interests [8]. - The remaining funds from the terminated project will be retained in dedicated accounts for future investment opportunities [8]. Delay of Fundraising Projects - The "Weike Medical Minimally Invasive Surgical New Product Project" will be delayed, with the expected completion date pushed from June 30, 2025, to December 31, 2027 [9]. - The delay is attributed to changes in market conditions and the need for further product development to meet diverse customer needs [9]. Reasons for Project Delay - The company is adapting to market changes and enhancing product features through increased R&D investment, which has necessitated a phased approach to project implementation [9]. - The execution of procurement policies has affected the expected market release timeline for the company's products [9]. Impact of Project Delay - The delay is a strategic decision that does not involve changes to the project’s implementation structure or total investment, ensuring that it aligns with the company's long-term development goals [9][10].

Core Viewpoint - The successful completion of the 100th laparoscopic surgery in Eritrea marks a significant milestone in the country's medical history, showcasing the achievements of the 17th Chinese medical team and the advancement of medical cooperation between China and Eritrea [1][4][8]. Group 1: Medical Achievements - The Chinese medical team initiated laparoscopic surgery in Eritrea, which was previously non-existent, and achieved a milestone of 100 successful surgeries within a year [1][2]. - The first laparoscopic surgery was performed on August 12, 2024, benefiting a 42-year-old appendicitis patient, demonstrating the efficiency of laparoscopic techniques compared to traditional open surgery [4][5]. - The medical team implemented a "1+1+1" teaching model, allowing local doctors to gain hands-on experience and eventually leading to one local doctor being able to perform surgeries independently [5][7]. Group 2: Training and Capacity Building - The team adopted a "three-step" strategy to establish laparoscopic surgery, which included hardware upgrades, technical training, and clinical practice [2]. - Local doctors received comprehensive training through theoretical lectures, simulated training, and on-site guidance, resulting in improved surgical skills and knowledge [2][5]. - The establishment of a minimally invasive center is planned to extend the training and techniques to surrounding provinces within three years [5][7]. Group 3: Cultural Exchange and Community Impact - The successful surgeries fostered a strong bond between the Chinese medical team and the local community, with expressions of gratitude from patients and local doctors [7][8]. - Celebratory events were held to honor the achievements, highlighting the cultural exchange and appreciation for the Chinese medical team's contributions [4][7]. - Over 80% of patients expressed positive feelings post-surgery, indicating a significant impact on patient satisfaction and community health perception [7].